Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -2.19% is 92% above its 5-year average of -26.42%, near the high end of its 5-year range (-46.97%–-2.19%).
As of the fiscal period ended Tuesday, June 30, 2026. 89.00% above its 12-month average of -19.92%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -2.19%.
RETURN ON INVESTED CAPITAL (ROIC)
-2.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-19.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-29.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-26.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+89.00%
CURRENT VS 3Y AVG
+92.52%
CURRENT VS 5Y AVG
+91.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
+93.51%
vs the sector median at left
Arvinas, Inc.
Market Cap
$479.39M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-19.92%
3Y Avg
-29.29%
5Y Avg
-26.42%
Market Cap
$474.59M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$473.31M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-33.80%
3Y Avg
-80.16%
5Y Avg
-71.70%
Market Cap
$472.52M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
Market Cap
$472.65M
Return on Invested Capital (ROIC)
6.95%
TTM Avg
6.49%
3Y Avg
4.50%
5Y Avg
4.55%
Market Cap
$487.36M
Return on Invested Capital (ROIC)
18.26%
TTM Avg
19.81%
3Y Avg
16.87%
5Y Avg
7.92%
Market Cap
$490.62M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$498.01M
Return on Invested Capital (ROIC)
-39.63%
TTM Avg
-67.88%
3Y Avg
-87.45%
5Y Avg
-79.46%
Market Cap
$460.65M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $479.39M | -2.19% | -19.92% | -29.29% | -26.42% |
| Cerus Corporation (CERS)vs › | $474.59M | -1.08% | -7.18% | -14.01% | -19.76% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.31M | -13.15% | -33.80% | -80.16% | -71.70% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $472.52M | -27.22% | -25.30% | -27.88% | -30.72% |
| Kamada Ltd. (KMDA)vs › | $472.65M | 6.95% | 6.49% | 4.50% | 4.55% |
| Puma Biotechnology, Inc. (PBYI)vs › | $487.36M | 18.26% | 19.81% | 16.87% | 7.92% |
| Evolus, Inc. (EOLS)vs › | $490.62M | -15.54% | -22.63% | -32.48% | -46.23% |
| Oculis Holding AG (OCS)vs › | $498.01M | -39.63% | -67.88% | -87.45% | -79.46% |
| NRC Health (NRC)vs › | $460.65M | 8.75% | 20.32% | 26.86% | 29.17% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | -34.79% | -53.61% | -51.25% | -40.96% |
ROIC
-2.2%
ROE
1.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -2.19% |
| 2026-03-31 | -46.97% |
| 2025-12-31 | -20.09% |
| 2025-09-30 | -14.56% |
| 2025-06-30 | -15.78% |
| 2025-03-31 | -12.15% |
| 2024-12-31 | -29.05% |
| 2024-09-30 | -40.10% |
| 2024-06-30 | -39.79% |
| 2024-03-31 | -40.86% |
| 2023-12-31 | -38.33% |
| 2023-09-30 | -42.04% |
| 2023-06-30 | -38.88% |
| 2023-03-31 | -32.83% |
| 2022-12-31 | -27.03% |
| 2022-09-30 | -22.22% |
| 2022-06-30 | -19.27% |
| 2022-03-31 | -16.90% |
| 2021-12-31 | -14.80% |
| 2021-09-30 | -12.94% |
| 2021-06-30 | -27.99% |
| 2021-03-31 | -22.32% |
| 2020-12-31 | -18.69% |
| 2020-09-30 | -44.93% |
| 2020-06-30 | -29.35% |
| 2020-03-31 | -23.72% |
| 2019-12-31 | -19.17% |
| 2019-09-30 | -25.42% |
| 2019-06-30 | -43.16% |
| 2019-03-31 | -33.32% |
| 2018-12-31 | -24.82% |
| 2018-09-30 | -40.60% |
| 2018-06-30 | -27.60% |
| 2018-03-31 | -22.92% |
| 2017-12-31 | -50.37% |
